Obalon_Logo_Teal_2c.jpg
Obalon Announces First Quarter 2021 Financial Results
May 12, 2021 08:40 ET | Obalon Therapeutics, Inc.
SAN DIEGO, May 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Fourth Quarter and Full Year 2020 Financial Results
March 12, 2021 19:12 ET | Obalon Therapeutics, Inc.
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Third Quarter 2020 Financial Results
November 06, 2020 16:45 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System
August 13, 2020 07:00 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Second Quarter 2020 Financial Results
July 30, 2020 06:38 ET | Obalon Therapeutics, Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces First Quarter 2020 Financial Results and Business Update
June 19, 2020 06:15 ET | Obalon Therapeutics, Inc.
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
May 11, 2020 08:30 ET | Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
Obalon_Logo_Teal_2c.jpg
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
May 08, 2020 08:00 ET | Obalon Therapeutics, Inc.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon_Logo_Teal_2c.jpg
Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons
April 28, 2020 09:00 ET | Obalon Therapeutics, Inc.
SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives
March 25, 2020 08:30 ET | Obalon Therapeutics, Inc.
SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...